Amylyx Pharmaceuticals Inc Logo

Amylyx Pharmaceuticals Inc (AMLX): Eigentümerstruktur

Takani Score ?
45.6

Preis (03.09.2026)52W Hoch52W Tief
33,96 US Dollar41,14 US Dollar9,75 US Dollar
Analysten KonsensBuyOutperformHoldUnderperformSell
42,364 US Dollar51100
Externe Analystenschätzungen (Quelle: EODHD) – keine Anlageempfehlung von Takani.
#SharesShort [%]Short Ratio
111.423.04815,587,01

Eigentümerstruktur

Analyse der Aktionärsstruktur und institutionellen Investoren

Unternehmensdaten

Grundlegende Informationen

Grunddaten

Name Amylyx Pharmaceuticals Inc
Mitarbeiter 136
Handelsplatz NASDAQ
Ticker Symbol AMLX
IPO Datum 2022-01-07
Adresse 55 Cambridge Parkway, Cambridge, MA, United States, 02142

Unternehmensführung

RangNamePosition
1Mr. Joshua B. CohenCo-Founder, Co-CEO & Director
2Mr. Justin B. KleeCo-CEO & Director
3Mr. James M. Frates M.B.A.Chief Financial Officer
4Dr. Camille L. Bedrosian M.D.Chief Medical Officer
5Mr. Tom HolmesChief Technical Operations Officer
6Ms. Lindsey AllenHead of Investor Relations & Communications
7Ms. Gina M. Mazzariello J.D.Chief Legal Officer & General Counsel
8Ms. Linda A. ArsenaultChief Human Resources Officer
9Ms. Tammy SarnelliGlobal Head of Regulatory Affairs
10Dr. Machelle Manuel Ph.D.VP & Head of Global Medical Affairs

Aktionärsverteilung

Aufteilung der Investoren

Größte Investoren

RangInhaberAnteileWert
1FMR Inc14,93%0,57 Mrd. USD
2BlackRock Inc7,92%0,31 Mrd. USD
3Perceptive Advisors LLC7,44%0,29 Mrd. USD
4TCG Crossover Management, LLC5,60%0,22 Mrd. USD
5COMMODORE CAPITAL LP5,07%0,20 Mrd. USD
6HHG PLC4,47%0,17 Mrd. USD
7Saturn V Capital Management LLC4,15%0,16 Mrd. USD
8Vanguard Capital Management, LLC3,72%0,14 Mrd. USD
9First Light Asset Management, LLC2,71%0,10 Mrd. USD
10Driehaus Capital Management LLC2,68%0,10 Mrd. USD
11The Goldman Sachs Group Inc2,36%0,09 Mrd. USD
12State Street Corp2,12%0,08 Mrd. USD
13Franklin Templeton Inc2,03%0,08 Mrd. USD
14Geode Capital Management, LLC1,98%0,08 Mrd. USD
15Morgan Stanley - Brokerage Accounts1,95%0,08 Mrd. USD
16Almitas Capital LLC1,91%0,07 Mrd. USD
17Adage Capital Partners Gp LLC1,71%0,07 Mrd. USD
18683 Capital Management LLC1,37%0,05 Mrd. USD
19StemPoint Capital LP1,20%0,05 Mrd. USD
20Bank of America Corp1,19%0,05 Mrd. USD